FIELD: medicine.
SUBSTANCE: method involves obtaining a sample from said patient, determining the level of DPP3 in said sample, wherein the level of DPP3 in said sample is an indicator of whether treatment with an anti-ADM antibody, or an anti-ADM antibody fragment, or an anti-ADM framework other than an Ig framework, is required.
EFFECT: disclosed is a method of performing therapy, and/or therapeutic monitoring, and/or therapeutic stratification of a patient suffering shock and/or a patient falling into shock.
27 cl, 8 ex, 7 tbl, 10 dwg
| Title |
Year |
Author |
Number |
| THERAPEUTIC GUIDANCE AND/OR MONITORING THERAPY FOR TREATING SHOCK |
2020 |
|
RU2835616C1 |
| ANTIBODY AGAINST ADRENOMEDULLIN (ADM), OR FRAGMENT OF ANTI-ADM ANTIBODY, OR ANTI-ADM NON-IG FRAME FOR USE IN INTERVENTION AND THERAPY OF HYPEREMIA IN PATIENT |
2017 |
|
RU2762059C2 |
| THERAPY MONITORING IN TREATMENT WITH BINDING AGENT AGAINST ADRENOMEDULLIN (ADM) |
2018 |
- Struck, Joachim
- Bergmann, Andreas
|
RU2776811C2 |
| COMPOUND BINDING ADRENOMEDULLIN (ADM) FOR USE FOR THERAPY OR PREVENTION OF DISEASE SYMPTOMS |
2018 |
|
RU2790561C2 |
| DPP3-BINDING MOLECULE AIMED AT SPECIFIC DPP3 EPITOPES AND BINDING TO THEM AND ITS USE FOR PREVENTION OR TREATMENT OF DISEASES/ACUTE CONDITIONS, WHICH ARE RELATED TO OXIDATIVE STRESS |
2018 |
|
RU2787033C2 |
| ANTI-PCSK9 ANTIBODY, ITS ANTIGEN-BINDING DOMAIN AND MEDICAL APPLICATION THEREOF |
2016 |
- Tsyuj, Syandun
- E, Sin
- Syuj, Shaoyu
- Yuan, Bej
- Tsuj, Dunbin
- Khu, Tsiyue
- Chzhan, Lej
- Syuj, Chzhibin
- Tao, Vejkan
- Chzhan, Lyanshan
- Sun, Pyaoyan
|
RU2739208C2 |
| ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE |
2019 |
- Beaumont, Kevin Charles
- Breen, Danna M.
- Chabot, Jeffrey Raymond
- He, Tao
- Shchors, Ksenya
- Apgar, James R.
- Lambert, Matthew Allister
|
RU2795457C2 |
| THERAPEUTIC PRODUCT CONTAINING IL-33 ANTAGONIST FOR THE TREATMENT OF ENDOMETRIOSIS |
2018 |
- Yoshimoto, Tomohiro
- Palumbo, M. Joseph
- Stone, I. Violetta
- Kato, Toru
- Yasuda, Koubun
|
RU2791705C2 |
| ANTI-PD-1 ANTIBODIES |
2019 |
- Fayadat-Dilman, Lorens
- Tszyuan, Veronika
- Khan, Shirin
- Khuan, Shaopen
- In, Khua
|
RU2788095C2 |
| COMBINATION CANCER THERAPIES TARGETTING CD38 AND TGF-BETA |
2019 |
- Adrian, Francisco
- Gregory, Richard C.
- Shapiro, Gary
- Van De Velde, Helgi
|
RU2808632C2 |
